Sumera Qasim

Dr. Sumera Qasim

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Phytomedicine
Verified
Journal Article
Closed access
ALAlamgeer
Alamgeer
UHUmme Habiba Hasan
Umme Habiba Hasan
AUAmbreen Malik Uttra
Ambreen Malik Uttra
SQSumera Qasim
Sumera Qasim
JIJavaria Ikram
Javaria Ikram
ZNZahid Rasul Niazi
Zahid Rasul Niazi

26 August 2020 in Postgraduate Medical Journal
Verified
Journal Article
Open access
PDF file
Tauqeer Hussain MallhiTauqeer Hussain Mallhi
Tauqeer Hussain Mallhi
Yusra Habib KhanYusra Habib Khan
Yusra Habib Khan
NANasser Hadal Alotaibi
Nasser Hadal Alotaibi
AAAbdulaziz Ibrahim Alzarea
Abdulaziz Ibrahim Alzarea
AAAbdullah Salah Alanazi
Abdullah Salah Alanazi
NTNida Tanveer
Nida Tanveer

14 January 2021 in ACS Omega
Verified
Journal Article
Open access
SQSumera Qasim
Sumera Qasim
AAAlamgeer Alamgeer
Alamgeer Alamgeer
SKSaima Kalsoom
Saima Kalsoom
MSMuhammad Shahzad
Muhammad Shahzad
IBIshfaq Ali Bukhari
Ishfaq Ali Bukhari
SASibtain Afzal
Sibtain Afzal
The current investigation employed rosuvastatin for evaluation as an antiarthritic agent by in vitro and in vivo studies. In vitro studies comprised egg albumin and bovine serum albumin protein denaturation assays along with membrane stabilization assays, while in vivo studies comprised formaldehyde and complete Freund’s adjuvant (CFA)-provoked arthritis. The antioxidant potential was estimated via DPPH free radical scavenging and ferric reducing assays. Rosuvastatin significantly inhibited heat-provoked protein denaturation of egg albumin and bovine serum in a concentration-dependent way with the highest inhibition of 1225 ± 9.83 and 82.80 ± 4.03 at 6400 μg/mL. The percentage protection of the RBC membrane from hypotonicity-prompted lysis was found to be 80.67 ± 2.7. Rosuvastatin promisingly subdued formaldehyde-provoked arthritis, with maximum reduction (65.47%) of the paw volume being observed at a dose of 40 mg/kg. Rosuvastatin also significantly (p < 0.001) attenuated arthritis induced by CFA injection by reducing the paw volume and arthritic index. The reduction in the body weight due to CFA injection was also preserved by rosuvastatin treatment. Hematological and biochemical changes due to arthritis induction by CFA injection were also maintained near normal values by rosuvastatin. The histopathological and radiographic investigation also revealed the protective effect of rosuvastatin on preventing structural changes. Gene expression of IL-1β, TNF-α, and IL-6 was reduced, while IL-4 and IL-10 levels were elevated by rosuvastatin in comparison to those for the disease control group. Concentration-dependent antioxidant potential was shown by rosuvastatin. Thus, rosuvastatin possesses a notable antiarthritic potential as evidenced via in vitro and in vivo studies.

30 March 2023 in Molecules
Verified
Journal Article
Open access
PDF file
KSKainat Shafique
Kainat Shafique
AFAftab Farrukh
Aftab Farrukh
TATariq Mahmood Ali
Tariq Mahmood Ali
SQSumera Qasim
Sumera Qasim
LJLaila Jafri
Laila Jafri
SKSaima Kalsoom
Saima Kalsoom
In the present study, a new series of 1,2,3-triazole derivatives was synthesized via a click one-pot reaction. The synthesized compounds were found to be active during molecular docking studies against targeted protein 1T69 by using the Molecular Operating Environment (MOE) software. The designed and synthesized compounds were characterized by using FT-IR, 1H-NMR and LC-MS spectra. The synthesized triazole moieties were further screened for their α-amylase and α-glucosidase inhibitory activities. The preliminary activity analysis revealed that all the compounds showed good inhibition activity, ranging from moderate to high depending upon their structures and concentrations and compared to the standard drug acarbose. Both in silico and in vitro analysis indicated that the synthesized triazole molecules are potent for DM type-II. Out of all the compounds, compound K-1 showed the maximum antidiabetic activity with 87.01% and 99.17% inhibition at 800 µg/mL in the α-amylase and α-glucosidase inhibition assays, respectively. Therefore these triazoles may be further used as promising molecules for development of antidiabetic compounds.

16 May 2022 in ACS Omega
Verified
Journal Article
Open access
SAShaimaa R Ahmed
Shaimaa R Ahmed
MAMohammad M. Al-Sanea
Mohammad M. Al-Sanea
EMEhab M. Mostafa
Ehab M. Mostafa
SQSumera Qasim
Sumera Qasim
NANarek Abelyan
Narek Abelyan
FMFatma A. MOKHTAR
Fatma A. MOKHTAR
Euphorbia plants have been identified as potential sources of antitumor lead compounds. The current study aimed to isolate and identify the main active constituents of Euphorbia abyssinica latex followed by a cytotoxic evaluation. A network pharmacology approach was employed to predict the underlying mechanism. Finally, drug-likeness and ADMET studies were conducted for active compounds. The phytochemical investigation of the latex of E. abyssinica resulted in the isolation of two triterpenes, 3-acetyloxy-(3α)-urs-12-en-28-oic methyl ester (1) and lup-20(29)-en-3α,23-diol (2). The dichloromethane extract displayed potent cytotoxic activity against the MCF7 cell line with an IC50 value of 4.27 ± 0.12 μg/mL but weak activity against HepG2 and HeLa cell lines (IC50 = 20.47 ± 1.17 and 26.73 ± 2.99 μg/mL, respectively) compared to doxorubicin. Compound 1 showed an encouraging cytotoxic effect against MCF7 with IC50 = 4.20 ± 0.20 μg/mL, followed by compound 2 (IC50 = 5.8 ± 0.35 μg/mL). The network analysis revealed that the two isolated compounds are linked to 68 targets of human nature, among which 51 genes are linked to breast carcinomas and 5 targets (AR, CYP19A1, EGFR, PGR, and PTGS2) might be the top therapeutic targets of isolated compounds on breast cancer. Furthermore, the gene-enrichment analysis revealed that E. abyssinica could play a role in the treatment of breast cancer by striking 51 potential targets via mainly three signaling pathways: P13K-AKT, Wnt, and VEGF. Therefore, isolated triterpenes could be considered effective antitumor agents for breast cancer by elucidating their candidate target to alleviate breast cancer and related signaling pathways of the targets.

5 March 2020 in Inflammopharmacology
Verified
Journal Article
Closed access
PDF file
SQSumera Qasim
Sumera Qasim
AAAlamgeer Alamgeer
Alamgeer Alamgeer
SKSaima Kalsoom
Saima Kalsoom
MSMuhammad Shahzad
Muhammad Shahzad
HIHafiz Muhammad Irfan
Hafiz Muhammad Irfan
SASibtain Afzal
Sibtain Afzal